JP2007506768A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007506768A5 JP2007506768A5 JP2006528240A JP2006528240A JP2007506768A5 JP 2007506768 A5 JP2007506768 A5 JP 2007506768A5 JP 2006528240 A JP2006528240 A JP 2006528240A JP 2006528240 A JP2006528240 A JP 2006528240A JP 2007506768 A5 JP2007506768 A5 JP 2007506768A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- less
- particles
- composition according
- diameter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002245 particle Substances 0.000 claims 20
- 229960002744 mometasone furoate Drugs 0.000 claims 15
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 claims 15
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 8
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 claims 3
- 229960001664 mometasone Drugs 0.000 claims 3
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 claims 3
- 208000000884 Airway Obstruction Diseases 0.000 claims 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50646803P | 2003-09-26 | 2003-09-26 | |
| US55159604P | 2004-03-09 | 2004-03-09 | |
| PCT/US2004/031444 WO2005030220A1 (en) | 2003-09-26 | 2004-09-24 | Pulmonary disease treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007506768A JP2007506768A (ja) | 2007-03-22 |
| JP2007506768A5 true JP2007506768A5 (https=) | 2007-10-11 |
Family
ID=34396317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006528240A Pending JP2007506768A (ja) | 2003-09-26 | 2004-09-24 | 肺疾患処置 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20050148563A1 (https=) |
| EP (1) | EP1667687A1 (https=) |
| JP (1) | JP2007506768A (https=) |
| CA (1) | CA2540005A1 (https=) |
| MX (1) | MXPA06003376A (https=) |
| WO (1) | WO2005030220A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010148262A1 (en) * | 2009-06-17 | 2010-12-23 | Mark Rutenberg | Treatment of acute pulmonary inflammation induced by cigarette smoking |
| JOP20120023B1 (ar) | 2011-02-04 | 2022-03-14 | Novartis Ag | صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية |
| EP2641900A1 (en) | 2012-03-20 | 2013-09-25 | Almirall, S.A. | Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor. |
| EP2668941A1 (en) * | 2012-05-31 | 2013-12-04 | Almirall, S.A. | Novel dosage form and formulation of abediterol |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5192528A (en) * | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
| PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| US5837699A (en) * | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
| US6503537B2 (en) * | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
| WO1998041193A1 (en) * | 1997-03-20 | 1998-09-24 | Schering Corporation | Preparation of powder agglomerates |
| WO1999018971A1 (en) * | 1997-10-09 | 1999-04-22 | Schering Corporation | Mometasone furoate suspensions for nebulization |
| SE9801368D0 (sv) * | 1998-04-20 | 1998-04-20 | Astra Ab | New use |
| AR022695A1 (es) * | 1999-01-28 | 2002-09-04 | Schering Corp | PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION |
| GB9904919D0 (en) * | 1999-03-03 | 1999-04-28 | Novartis Ag | Organic compounds |
| GB0009609D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Therapeutic compositions |
| GB0123951D0 (en) * | 2001-10-05 | 2001-11-28 | Glaxo Group Ltd | Therapies for treating respiratory diseases |
-
2004
- 2004-09-24 CA CA002540005A patent/CA2540005A1/en not_active Abandoned
- 2004-09-24 WO PCT/US2004/031444 patent/WO2005030220A1/en not_active Ceased
- 2004-09-24 MX MXPA06003376A patent/MXPA06003376A/es unknown
- 2004-09-24 JP JP2006528240A patent/JP2007506768A/ja active Pending
- 2004-09-24 EP EP04785005A patent/EP1667687A1/en not_active Withdrawn
- 2004-09-24 US US10/948,987 patent/US20050148563A1/en not_active Abandoned
-
2007
- 2007-09-05 US US11/850,509 patent/US20080107609A1/en not_active Abandoned
-
2011
- 2011-04-25 US US13/093,307 patent/US20110200647A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6099609B2 (ja) | 肺炎症を低減するためのレボフロキサシンの吸入 | |
| ES2200837T3 (es) | Combinaciones de formoterol y furoato de mometasona. | |
| PT1326595E (pt) | Composicao farmaceutica compreendendo resveratrol para o tratamento de disturbios respiratorios inflamatorios | |
| JP2005508371A5 (https=) | ||
| JP2012503668A5 (https=) | ||
| WO2007109118A3 (en) | RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS | |
| CA2550841A1 (en) | Novel combination of anticholinergic and .beta. mimetics for the treatment of respiratory diseases | |
| JP2008505857A5 (https=) | ||
| Kilfeather et al. | Improved delivery of ipratropium bromide/fenoterol from Respimat® Soft MistTM Inhaler in patients with COPD | |
| JP2007119497A5 (https=) | ||
| JP2007506768A5 (https=) | ||
| HUE031442T2 (en) | Aclidinium for use in improving the quality of sleep in respiratory patients. | |
| JP2009534367A5 (https=) | ||
| Beeh et al. | Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases | |
| CA2506962A1 (en) | Synergistic combination comprising roflumilast and formoterol | |
| JP2008502699A5 (https=) | ||
| JP2006508994A5 (https=) | ||
| JP2017511307A5 (https=) | ||
| JP2010523662A5 (https=) | ||
| WO2007046113A3 (en) | Novel pharmaceutical composition comprising alkaloid and process thereof | |
| CN103168038A (zh) | 用于治疗咳嗽的碳酸酯衍生物 | |
| CA2506956A1 (en) | Synergistic combination comprising roflumilast and (r,r)-formoterol | |
| NO20033451L (no) | Medikamenter | |
| Vogelberg et al. | Dose-ranging study of tiotropium as treatment for moderate persistent asthma in adolescents | |
| McDonald et al. | Comparison of oral bambuterol and terbutaline in elderly patients with chronic reversible airflow obstruction |